Flynn S, Mosher C, Cornelison S, Rao E, Metzler K, Pu W
Int J Chron Obstruct Pulmon Dis. 2025; 20:231-241.
PMID: 39906676
PMC: 11792638.
DOI: 10.2147/COPD.S484558.
Kerwin E, Jones P, Bjermer L, Maltais F, Boucot I, Naya I
Chron Respir Dis. 2023; 20:14799731231202257.
PMID: 37800633
PMC: 10903204.
DOI: 10.1177/14799731231202257.
Tessarin G, Baronio M, Gazzurelli L, Rossi S, Chiarini M, Moratto D
J Clin Immunol. 2023; 43(8):2091-2103.
PMID: 37755605
PMC: 10661825.
DOI: 10.1007/s10875-023-01587-4.
Namusobya M, Bongomin F, Mukisa J, Batte C, Olwit W, Rhein J
Mycopathologia. 2023; 188(5):713-720.
PMID: 37195546
DOI: 10.1007/s11046-023-00741-1.
Vendetti M, Esther Moon S, Imes C, Hergenroeder A, Sciurba F, Lendermon E
Contemp Clin Trials Commun. 2023; 33:101097.
PMID: 36911577
PMC: 9999171.
DOI: 10.1016/j.conctc.2023.101097.
The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda.
Namusobya M, Bongomin F, Mukisa J, Batte C, Olwit W, Rhein J
Res Sq. 2023; .
PMID: 36711486
PMC: 9882611.
DOI: 10.21203/rs.3.rs-2389854/v1.
Longitudinal follow-up of postacute COVID-19 syndrome: DL, quality-of-life and MRI pulmonary gas-exchange abnormalities.
Matheson A, McIntosh M, Kooner H, Abdelrazek M, Albert M, Dhaliwal I
Thorax. 2023; 78(4):418-421.
PMID: 36596692
PMC: 10086459.
DOI: 10.1136/thorax-2022-219378.
Daily Physical Activity in Asthma and the Effect of Mepolizumab Therapy.
Panagiotou M, Koulouris N, Koutsoukou A, Rovina N
J Pers Med. 2022; 12(10).
PMID: 36294831
PMC: 9605576.
DOI: 10.3390/jpm12101692.
Wood smoke exposure affects lung aging, quality of life, and all-cause mortality in New Mexican smokers.
Leng S, Picchi M, Meek P, Jiang M, Bayliss S, Zhai T
Respir Res. 2022; 23(1):236.
PMID: 36076291
PMC: 9454202.
DOI: 10.1186/s12931-022-02162-y.
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
Menzies-Gow A, Gurnell M, Heaney L, Corren J, Bel E, Maspero J
Eur Respir J. 2022; 60(6).
PMID: 35896216
PMC: 9791910.
DOI: 10.1183/13993003.03226-2021.
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
Buhr R, Barjaktarevic I, Quibrera P, Bateman L, Bleecker E, Couper D
Am J Respir Crit Care Med. 2022; 206(5):554-562.
PMID: 35549640
PMC: 9716898.
DOI: 10.1164/rccm.202201-0094OC.
Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India.
Khurana A, Hussain A, Goyal A, Tejpal Karna S, Saigal S, Soman R
Turk Thorac J. 2022; 23(2):89-96.
PMID: 35404239
PMC: 9449983.
DOI: 10.5152/TurkThoracJ.2022.21159.
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
Cella D, Motzer R, Suarez C, Blum S, Ejzykowicz F, Hamilton M
Lancet Oncol. 2022; 23(2):292-303.
PMID: 35032437
PMC: 9479564.
DOI: 10.1016/S1470-2045(21)00693-8.
A primary care medical home approach to pulmonary rehabilitation.
Yurchak S, Rawlinson A, Schaub J, Shpilkerman Y, Makarowski C, Goddard K
Can J Respir Ther. 2021; 57:161-166.
PMID: 34963884
PMC: 8698156.
DOI: 10.29390/cjrt-2021-040.
Patient's awareness on COPD is the strongest predictor of persistence and adherence in treatment-naïve patients in real life: a prospective cohort study.
Lopez-Pintor E, Grau J, Lumbreras B
BMC Pulm Med. 2021; 21(1):388.
PMID: 34837978
PMC: 8627039.
DOI: 10.1186/s12890-021-01754-6.
Validation of a Spanish version of the Leicester Cough Questionnaire in cystic fibrosis.
Munoz G, De Gracia J, Giron R, Olveira C, Alvarez A, Buxo M
Chron Respir Dis. 2021; 18:14799731211036903.
PMID: 34730449
PMC: 8743974.
DOI: 10.1177/14799731211036903.
Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study.
Hansel N, Putcha N, Woo H, PenG R, Diette G, Fawzy A
Am J Respir Crit Care Med. 2021; 205(4):421-430.
PMID: 34449285
PMC: 8886948.
DOI: 10.1164/rccm.202103-0604OC.
Utility of St. George's respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis.
Bongomin F, Otu A
Ther Adv Infect Dis. 2021; 8:20499361211034643.
PMID: 34377466
PMC: 8323403.
DOI: 10.1177/20499361211034643.
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.
Bjermer L, Boucot I, Vogelmeier C, Maltais F, Jones P, Tombs L
Adv Ther. 2021; 38(9):4815-4835.
PMID: 34347255
PMC: 8408076.
DOI: 10.1007/s12325-021-01855-y.
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease.
Balasubramanian A, Henderson R, Putcha N, Fawzy A, Raju S, Hansel N
ERJ Open Res. 2021; 7(3).
PMID: 34322549
PMC: 8311135.
DOI: 10.1183/23120541.00068-2021.